Being on a GLP-1 can feel… complicated, especially if you have a history of dieting, body image challenges, medical trauma, or anti-diet work under your belt. The excitement, fear, shame, relief, doubt, and curiosity can all be present at the same time. That’s where our work together begins.
The media is making these medications out to be like the “magic shot”. Unfortunately, it’s a lot more complicated than that. GLP-1s are the epitome of all things being true - the thrill and hope of finally feeling better, the worries of managing symptoms, unease about how your community will respond, and nervousness about undoing the years of recovery from diet culture. And at the end of the day, you deserve a space where all the feelings are welcome.
Culturally, folks use “GLP-1” as a catch-all phrase to reference any of these medications. There are differences, but not to worry - I can work with all of them!
Semaglutides (like Ozempic & Wegovy) are true GLP-1 agonists.
Tirzepatide (like Mounjaro & Zepbound) are dual agonists, meaning they are GLP-1s + GIP (glucose-dependent insulinotropic polypeptide).
Some of it is semantics, but there is a community of researchers and practitioners who are pushing for a total classification of these medications - Nutrient Stimulating Hormones (NuSH) that you may see more commonly in the coming months!
Heck no. I work with folks before, during, and after starting medication.
Absolutely. GLP-1s can be seriously health-changing, regardless of if they impact your body size. Values and lived experience can coexist.
Nope, that’s not the work we do around here.
First and foremost, totally valid. Secondly, it’s why I’m so passionate about the intersection of eating disorders and GLP-1s. I work with both. We will prioritize your emotional and physical wellbeing, not numbers or outcomes.